Metabolic Reprogramming in the Bladder Cancer Microenvironment: Bridging Fundamental Research and Therapeutic Avenues

Ana Silva1,2, Fátima Baltazar1,2, Julieta Afonso1,2

  • 1Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal.

Summary

Bladder cancer-associated fibroblasts (BCAFs) fuel tumor growth and resistance by altering cancer cell metabolism. Understanding this metabolic interplay is key to developing new bladder cancer therapies.